237 related articles for article (PubMed ID: 25759797)
1. Platelet-derived growth factor: a key factor in the pathogenesis of graves' ophthalmopathy and potential target for treatment.
Virakul S; van Steensel L; Dalm VA; Paridaens D; van Hagen PM; Dik WA
Eur Thyroid J; 2014 Dec; 3(4):217-26. PubMed ID: 25759797
[TBL] [Abstract][Full Text] [Related]
2. PDGF enhances orbital fibroblast responses to TSHR stimulating autoantibodies in Graves' ophthalmopathy patients.
van Steensel L; Hooijkaas H; Paridaens D; van den Bosch WA; Kuijpers RW; Drexhage HA; van Hagen PM; Dik WA
J Clin Endocrinol Metab; 2012 Jun; 97(6):E944-53. PubMed ID: 22438231
[TBL] [Abstract][Full Text] [Related]
3. Imatinib mesylate and AMN107 inhibit PDGF-signaling in orbital fibroblasts: a potential treatment for Graves' ophthalmopathy.
van Steensel L; Paridaens D; Schrijver B; Dingjan GM; van Daele PL; van Hagen PM; van den Bosch WA; Drexhage HA; Hooijkaas H; Dik WA
Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3091-8. PubMed ID: 19234339
[TBL] [Abstract][Full Text] [Related]
4. The tyrosine kinase inhibitor dasatinib effectively blocks PDGF-induced orbital fibroblast activation.
Virakul S; Dalm VA; Paridaens D; van den Bosch WA; Hirankarn N; van Hagen PM; Dik WA
Graefes Arch Clin Exp Ophthalmol; 2014 Jul; 252(7):1101-9. PubMed ID: 24874745
[TBL] [Abstract][Full Text] [Related]
5. Orbit-infiltrating mast cells, monocytes, and macrophages produce PDGF isoforms that orchestrate orbital fibroblast activation in Graves' ophthalmopathy.
van Steensel L; Paridaens D; van Meurs M; van Hagen PM; van den Bosch WA; Kuijpers RW; Drexhage HA; Hooijkaas H; Dik WA
J Clin Endocrinol Metab; 2012 Mar; 97(3):E400-8. PubMed ID: 22238384
[TBL] [Abstract][Full Text] [Related]
6. Basic Fibroblast Growth Factor Induces Adipogenesis in Orbital Fibroblasts: Implications for the Pathogenesis of Graves' Orbitopathy.
Schrijver B; Kooiman MA; Kasteleijn E; van Holten-Neelen C; Virakul S; Paridaens D; Peeters RP; van Hagen PM; Dalm VASH; Dik WA
Thyroid; 2019 Mar; 29(3):395-404. PubMed ID: 30724135
[TBL] [Abstract][Full Text] [Related]
7. Platelet-derived growth factor-BB: a stimulus for cytokine production by orbital fibroblasts in Graves' ophthalmopathy.
van Steensel L; Paridaens D; Dingjan GM; van Daele PL; van Hagen PM; Kuijpers RW; van den Bosch WA; Drexhage HA; Hooijkaas H; Dik WA
Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):1002-7. PubMed ID: 19797221
[TBL] [Abstract][Full Text] [Related]
8. Histone Deacetylase 4 Controls Extracellular Matrix Production in Orbital Fibroblasts from Graves' Ophthalmopathy Patients.
Ekronarongchai S; Palaga T; Saonanon P; Pruksakorn V; Hirankarn N; van Hagen PM; Dik WA; Virakul S
Thyroid; 2021 Oct; 31(10):1566-1576. PubMed ID: 34235979
[No Abstract] [Full Text] [Related]
9. EZH2 as a major histone methyltransferase in PDGF-BB-activated orbital fibroblast in the pathogenesis of Graves' ophthalmopathy.
Visamol S; Palaga T; Saonanon P; Pruksakorn V; Hirankarn N; van Hagen PM; Dik WA; Virakul S
Sci Rep; 2024 Apr; 14(1):7947. PubMed ID: 38575707
[TBL] [Abstract][Full Text] [Related]
10. Platelet-Derived Growth Factor-BB Enhances Adipogenesis in Orbital Fibroblasts.
Virakul S; Dalm VA; Paridaens D; van den Bosch WA; Mulder MT; Hirankarn N; van Hagen PM; Dik WA
Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5457-64. PubMed ID: 26284551
[TBL] [Abstract][Full Text] [Related]
11. Basic FGF and PDGF-BB synergistically stimulate hyaluronan and IL-6 production by orbital fibroblasts.
Virakul S; Heutz JW; Dalm VA; Peeters RP; Paridaens D; van den Bosch WA; Hirankarn N; van Hagen PM; Dik WA
Mol Cell Endocrinol; 2016 Sep; 433():94-104. PubMed ID: 27267669
[TBL] [Abstract][Full Text] [Related]
12. Current perspectives on the role of orbital fibroblasts in the pathogenesis of Graves' ophthalmopathy.
Dik WA; Virakul S; van Steensel L
Exp Eye Res; 2016 Jan; 142():83-91. PubMed ID: 26675405
[TBL] [Abstract][Full Text] [Related]
13. Effects of thyrotropin and thyrotropin-receptor-stimulating Graves' disease immunoglobulin G on cyclic adenosine monophosphate and hyaluronan production in nondifferentiated orbital fibroblasts of Graves' ophthalmopathy patients.
van Zeijl CJ; Fliers E; van Koppen CJ; Surovtseva OV; de Gooyer ME; Mourits MP; Wiersinga WM; Miltenburg AM; Boelen A
Thyroid; 2010 May; 20(5):535-44. PubMed ID: 20384487
[TBL] [Abstract][Full Text] [Related]
14. Human placenta-derived mesenchymal stem cells ameliorate orbital adipogenesis in female mice models of Graves' ophthalmopathy.
Park M; Banga JP; Kim GJ; Kim M; Lew H
Stem Cell Res Ther; 2019 Aug; 10(1):246. PubMed ID: 31399042
[TBL] [Abstract][Full Text] [Related]
15. The orbital fibroblast: a key player and target for therapy in graves' ophthalmopathy.
van Steensel L; Dik WA
Orbit; 2010 Aug; 29(4):202-6. PubMed ID: 20812837
[TBL] [Abstract][Full Text] [Related]
16. Whole orbital tissue culture identifies imatinib mesylate and adalimumab as potential therapeutics for Graves' ophthalmopathy.
van Steensel L; van Hagen PM; Paridaens D; Kuijpers RW; van den Bosch WA; Drexhage HA; Hooijkaas H; Dik WA
Br J Ophthalmol; 2011 May; 95(5):735-8. PubMed ID: 21310803
[TBL] [Abstract][Full Text] [Related]
17. Molecular biomarkers of Graves' ophthalmopathy.
Longo CM; Higgins PJ
Exp Mol Pathol; 2019 Feb; 106():1-6. PubMed ID: 30414981
[TBL] [Abstract][Full Text] [Related]
18. [Interactions of fibroblasts, adipocytes and immunocompeent cells in the pathogenesis of endocrine ophthalmopathy].
Heufelder AE
Acta Med Austriaca; 2001; 28(4):89-92. PubMed ID: 11593897
[TBL] [Abstract][Full Text] [Related]
19. Glucocorticoids Directly Affect Hyaluronan Production of Orbital Fibroblasts; A Potential Pleiotropic Effect in Graves' Orbitopathy.
Galgoczi E; Katko M; Papp FR; Csiki R; Csiha S; Erdei A; Bodor M; Ujhelyi B; Steiber Z; Gyory F; Nagy EV
Molecules; 2022 Dec; 28(1):. PubMed ID: 36615214
[TBL] [Abstract][Full Text] [Related]
20. Pathogenesis of Graves' ophthalmopathy: the role of autoantibodies.
Khoo TK; Bahn RS
Thyroid; 2007 Oct; 17(10):1013-8. PubMed ID: 17935483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]